_1777294237270_124456903.png&w=64&q=75){kind=small}
Injection lowers harmful internal fat by 12 percent
A preliminary study has found that an experimental injection called "CBL-514" can reduce visceral fat around internal abdominal organs by 12%. The injection is used to stimulate programmed cell death (apoptosis) selectively in fat cells, thereby decreasing fat size and positively impacting metabolism and insulin resistance. The study requires further trials to confirm its safety and effectiveness before final approval, but it shows promise in treating dangerous fat levels that increase the risk of diabetes and heart disease.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)